Literature DB >> 33411638

Exercise protects against cardiac and skeletal muscle dysfunction in a mouse model of inflammatory arthritis.

Kim M Huffman1,2,3, Brian J Andonian1,2, Dennis M Abraham1, Akshay Bareja1,2, David E Lee1,2, Lauren H Katz1,2,4, Janet L Huebner2, William E Kraus1,2,3, James P White1,2,3.   

Abstract

Rheumatoid arthritis (RA) is a systemic inflammatory arthritis impacting primarily joints and cardiac and skeletal muscle. RA's distinct impact on cardiac and skeletal muscle tissue is suggested by studies showing that new RA pharmacologic agents strongly improve joint inflammation, but have little impact on RA-associated mortality, cardiovascular disease, and sarcopenia. Thus, the objective is to understand the distinct effects of RA on cardiac and skeletal muscle, and to therapeutically target these tissues through endurance-based exercise as a way to improve RA mortality and morbidity. We utilize the well-characterized RA mouse model, the K/BxN mouse, to investigate cardiac and skeletal muscle pathologies, including the use of wheel-running exercise to mitigate these pathologies. Strikingly, we found that K/BxN mice, like patients with RA, also exhibit both cardiac and skeletal muscle myopathies that were correlated with circulating IL-6 levels. Three months of wheel-running exercise significantly improved K/BxN joint swelling and reduced systemic IL-6 concentrations. Importantly, there were morphological, gene expression, and functional improvements in both the skeletal muscle and cardiac myopathies with exercise. The K/BxN mouse model of RA recapitulated important RA clinical comorbidities, including altered joint, cardiac and skeletal muscle function. These morphological, molecular, and functional alterations were mitigated with regular exercise, thus suggesting exercise as a potential therapeutic intervention to lessen disease activity in the joint and the peripheral tissues, including the heart and skeletal muscle.NEW & NOTEWORTHY RA, even when controlled, is associated with skeletal muscle weakness and greater risk of cardiovascular disease (CVD). Using exercise as a therapeutic against, the progression of RA is often avoided due to fear of worsening RA pathology. We introduce the K/BxN mouse as an RA model to study both myocardial and skeletal muscle dysfunction. We show that endurance exercise can improve joint, cardiac, and skeletal muscle function in K/BxN mice, suggesting exercise may be beneficial for patients with RA.

Entities:  

Keywords:  arthritis; exercise; heart; inflammation; muscle

Mesh:

Year:  2021        PMID: 33411638      PMCID: PMC7988790          DOI: 10.1152/japplphysiol.00576.2020

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  69 in total

1.  Selective Sexual Dimorphisms in Musculoskeletal and Cardiopulmonary Pathologic Manifestations and Mortality Incidence in the Tumor Necrosis Factor-Transgenic Mouse Model of Rheumatoid Arthritis.

Authors:  Richard D Bell; Emily K Wu; Christopher A Rudmann; Megan Forney; Claire R W Kaiser; Ronald W Wood; Joe V Chakkalakal; Nicole D Paris; Alanna Klose; Guang-Qian Xiao; Javier Rangel-Moreno; Maria L Garcia-Hernandez; Christopher T Ritchlin; Edward M Schwarz; Homaira Rahimi
Journal:  Arthritis Rheumatol       Date:  2019-07-22       Impact factor: 10.995

2.  Exercise is Associated With Increased Small HDL Particle Concentration and Decreased Vascular Stiffness in Rheumatoid Arthritis.

Authors:  Kevin W Byram; Annette M Oeser; MacRae F Linton; Sergio Fazio; C Michael Stein; Michelle J Ormseth
Journal:  J Clin Rheumatol       Date:  2018-12       Impact factor: 3.517

3.  STAR: ultrafast universal RNA-seq aligner.

Authors:  Alexander Dobin; Carrie A Davis; Felix Schlesinger; Jorg Drenkow; Chris Zaleski; Sonali Jha; Philippe Batut; Mark Chaisson; Thomas R Gingeras
Journal:  Bioinformatics       Date:  2012-10-25       Impact factor: 6.937

4.  Relationship between weakness and muscle wasting in rheumatoid arthritis.

Authors:  P S Helliwell; S Jackson
Journal:  Ann Rheum Dis       Date:  1994-11       Impact factor: 19.103

5.  Inhibition of signal transducer and activator of transcription 3 (STAT3) attenuates interleukin-6 (IL-6)-induced collagen synthesis and resultant hypertrophy in rat heart.

Authors:  Saiful Anam Mir; Arunachal Chatterjee; Arkadeep Mitra; Kanchan Pathak; Sushil K Mahata; Sagartirtha Sarkar
Journal:  J Biol Chem       Date:  2011-12-07       Impact factor: 5.157

6.  MeCP2 in the nucleus accumbens contributes to neural and behavioral responses to psychostimulants.

Authors:  Jie V Deng; Ramona M Rodriguiz; Ashley N Hutchinson; Il-Hwan Kim; William C Wetsel; Anne E West
Journal:  Nat Neurosci       Date:  2010-08-15       Impact factor: 24.884

Review 7.  Diastolic dysfunction in rheumatoid arthritis: a meta-analysis and systematic review.

Authors:  Fawad Aslam; Salman J Bandeali; Nasim A Khan; Mahboob Alam
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-04       Impact factor: 4.794

8.  Meteorin-like facilitates skeletal muscle repair through a Stat3/IGF-1 mechanism.

Authors:  Gurpreet S Baht; Akshay Bareja; David E Lee; Rajesh R Rao; Rong Huang; Janet L Huebner; David B Bartlett; Corey R Hart; Jason R Gibson; Ian R Lanza; Virginia B Kraus; Simon G Gregory; Bruce M Spiegelman; James P White
Journal:  Nat Metab       Date:  2020-03-16

9.  Molecular alterations in skeletal muscle in rheumatoid arthritis are related to disease activity, physical inactivity, and disability.

Authors:  Kim M Huffman; Ryan Jessee; Brian Andonian; Brittany N Davis; Rachel Narowski; Janet L Huebner; Virginia B Kraus; Julie McCracken; Brian F Gilmore; K Noelle Tune; Milton Campbell; Timothy R Koves; Deborah M Muoio; Monica J Hubal; William E Kraus
Journal:  Arthritis Res Ther       Date:  2017-01-23       Impact factor: 5.156

10.  Collagen-induced arthritis as an animal model of rheumatoid cachexia.

Authors:  Paulo V G Alabarse; Priscila S Lora; Jordana M S Silva; Rafaela C E Santo; Eduarda C Freitas; Mayara S de Oliveira; Andrelise S Almeida; Mônica Immig; Vivian O N Teixeira; Lidiane I Filippin; Ricardo M Xavier
Journal:  J Cachexia Sarcopenia Muscle       Date:  2018-03-25       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.